$NEON
Neonode Inc Stock $neon

$neon Overview Financials Valuation SEC Filings Company Website

2014 Q4 Form 10-K Financial Statement

#000121390016011504 Filed on March 11, 2016

Income Statement

Concept	2014 Q4	2013 Q4	2013 Q3
Revenue	$1.735M	$1.009M	$1.076M
YoY Change	71.95%	-56.51%	-35.91%
Cost Of Revenue	$469.0K	$199.0K	$765.0K
YoY Change	135.68%	-48.31%	127.0%
Gross Profit	$1.266M	$810.0K	$311.0K
YoY Change	56.3%	-58.14%	-76.83%
Gross Profit Margin	72.97%	80.28%	28.9%
Selling, General & Admin	$2.330M	$1.900M	$1.378M
YoY Change	22.63%	1.06%	-31.31%
% of Gross Profit	184.04%	234.57%	443.09%
Research & Development	$2.080M	$1.950M	$2.211M
YoY Change	6.67%	-8.45%	52.38%
% of Gross Profit	164.3%	240.74%	710.93%
Depreciation & Amortization	$50.00K	$40.00K	$40.00K
YoY Change	25.0%	33.33%	33.33%
% of Gross Profit	3.95%	4.94%	12.86%
Operating Expenses	$4.410M	$3.840M	$3.589M
YoY Change	14.84%	-4.0%	3.82%
Operating Profit	-$3.144M	-$3.030M	-$3.278M
YoY Change	3.76%	46.73%	54.99%
Interest Expense	$80.00K	$0.00	$30.00K
YoY Change
% of Operating Profit
Other Income/Expense, Net	-$30.00K
YoY Change
Pretax Income	-$3.100M	-$3.030M	-$3.278M
YoY Change	2.31%	46.38%	54.99%
Income Tax	$10.00K	$10.00K	$65.00K
% Of Pretax Income
Net Earnings	-$3.107M	-$3.047M	-$3.343M
YoY Change	1.97%	43.19%	55.92%
Net Earnings / Revenue	-179.08%	-301.98%	-310.69%
Basic Earnings Per Share
Diluted Earnings Per Share	-$767.9K	-$802.6K	-$943.5K
COMMON SHARES
Basic Shares Outstanding	40.46M shares	37.93M shares	35.44M shares
Diluted Shares Outstanding			35.44M shares

Balance Sheet

Concept	2014 Q4	2013 Q4	2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.130M	$8.820M	$10.57M
YoY Change	-30.5%	-3.08%	-6.04%
Cash & Equivalents	$6.129M	$8.815M
Short-Term Investments
Other Short-Term Assets	$215.0K	$200.0K	$1.300M
YoY Change	7.5%	-6.54%	242.11%
Inventory
Prepaid Expenses
Receivables	$1.106M	$969.0K	$1.085M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$7.948M	$11.14M	$12.95M
YoY Change	-28.63%	-5.39%	-1.56%
LONG-TERM ASSETS
Property, Plant & Equipment	$654.0K	$335.0K	$365.0K
YoY Change	95.22%	1.52%	7.35%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets		$0.00	$70.00K
YoY Change		-100.0%
Total Long-Term Assets	$654.0K	$335.0K	$434.0K
YoY Change	95.22%	-15.83%	27.65%
TOTAL ASSETS
Total Short-Term Assets	$7.948M	$11.14M	$12.95M
Total Long-Term Assets	$654.0K	$335.0K	$434.0K
Total Assets	$8.602M	$11.47M	$13.38M
YoY Change	-25.01%	-5.73%	-0.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$566.0K	$479.0K	$426.0K
YoY Change	18.16%	-11.13%	-14.46%
Accrued Expenses	$935.0K	$978.0K	$896.0K
YoY Change	-4.4%	21.64%	21.57%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$60.00K
YoY Change
Total Short-Term Liabilities	$4.965M	$5.123M	$4.801M
YoY Change	-3.08%	25.93%	25.39%
LONG-TERM LIABILITIES
Long-Term Debt	$370.0K	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$370.0K	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.965M	$5.123M	$4.801M
Total Long-Term Liabilities	$370.0K	$0.00	$0.00
Total Liabilities	$5.332M	$5.123M	$4.801M
YoY Change	4.08%	25.93%	25.39%
SHAREHOLDERS EQUITY
Retained Earnings	-$165.9M	-$151.7M	-$148.6M
YoY Change	9.38%	9.44%	8.91%
Common Stock	$40.00K	$38.00K	$38.00K
YoY Change	5.26%	15.15%	15.15%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.270M	$6.348M	$8.582M
YoY Change
Total Liabilities & Shareholders Equity	$8.602M	$11.47M	$13.38M
YoY Change	-25.01%	-5.73%	-0.82%

Cashflow Statement

Concept	2014 Q4	2013 Q4	2013 Q3
OPERATING ACTIVITIES
Net Income	-$3.107M	-$3.047M	-$3.343M
YoY Change	1.97%	43.19%	55.92%
Depreciation, Depletion And Amortization	$50.00K	$40.00K	$40.00K
YoY Change	25.0%	33.33%	33.33%
Cash From Operating Activities	-$2.770M	-$2.270M	-$2.420M
YoY Change	22.03%	6.07%	952.17%
INVESTING ACTIVITIES
Capital Expenditures	-$20.00K	-$20.00K	-$110.0K
YoY Change	0.0%	0.0%	450.0%
Acquisitions
YoY Change
Other Investing Activities	$10.00K
YoY Change
Cash From Investing Activities	-$10.00K	-$20.00K	-$110.0K
YoY Change	-50.0%	0.0%	450.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$6.900M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-10.00K	550.0K	7.750M
YoY Change	-101.82%	816.67%	5066.67%
NET CHANGE
Cash From Operating Activities	-2.770M	-2.270M	-2.420M
Cash From Investing Activities	-10.00K	-20.00K	-110.0K
Cash From Financing Activities	-10.00K	550.0K	7.750M
Net Change In Cash	-2.790M	-1.740M	5.220M
YoY Change	60.34%	-17.14%	-5320.0%
FREE CASH FLOW
Cash From Operating Activities	-$2.770M	-$2.270M	-$2.420M
Capital Expenditures	-$20.00K	-$20.00K	-$110.0K
Free Cash Flow	-$2.750M	-$2.250M	-$2.310M
YoY Change	22.22%	6.13%	1000.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015	dei	Entity Registrant Name EntityRegistrantName	Neonode, Inc
CY2015	dei	Entity Central Index Key EntityCentralIndexKey	0000087050
CY2015	dei	Amendment Flag AmendmentFlag	false
CY2015	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2015	dei	Document Type DocumentType	10-K
CY2015	dei	Document Period End Date DocumentPeriodEndDate	2015-12-31
CY2015	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
CY2015	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2015	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2015	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2015	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2015	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2015Q2	dei	Entity Public Float EntityPublicFloat	101549947	usd
CY2016Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	43817151	shares
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9097000	usd
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8815000	usd
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6129000	usd
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3082000	usd
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1106000	usd
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1346000	usd
CY2014Q4	us-gaap	Investments In Power And Distribution Projects InvestmentsInPowerAndDistributionProjects	200000	usd
CY2015Q4	us-gaap	Investments In Power And Distribution Projects InvestmentsInPowerAndDistributionProjects	158000	usd
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	513000	usd
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	747000	usd
CY2014Q4	us-gaap	Assets Current AssetsCurrent	7948000	usd
CY2015Q4	us-gaap	Assets Current AssetsCurrent	5333000	usd
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	654000	usd
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	594000	usd
CY2014Q4	us-gaap	Assets Assets	8602000	usd
CY2015Q4	us-gaap	Assets Assets	5927000	usd
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	566000	usd
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	965000	usd
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	935000	usd
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1314000	usd
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3403000	usd
CY2015Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1475000	usd
CY2014Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	61000	usd
CY2015Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	57000	usd
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4965000	usd
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3811000	usd
CY2014Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	367000	usd
CY2015Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	283000	usd
CY2014Q4	us-gaap	Liabilities Liabilities	5332000	usd
CY2015Q4	us-gaap	Liabilities Liabilities	4094000	usd
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	40000	usd
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	44000	usd
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	169010000	usd
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	175504000	usd
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	149000	usd
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	46000	usd
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-165929000	usd
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-173749000	usd
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	8100000	usd
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	6348000	usd
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	3270000	usd
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	1845000	usd
CY2014Q4	us-gaap	Minority Interest MinorityInterest		usd
CY2015Q4	us-gaap	Minority Interest MinorityInterest	-12000	usd
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3270000	usd
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1833000	usd
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8602000	usd
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5927000	usd
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	70000000	shares
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	70000000	shares
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	40455352	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43805586	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	40455352	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43805586	shares
CY2013Q1	us-gaap	Revenues Revenues	548000	usd
CY2013Q2	us-gaap	Revenues Revenues	1084000	usd
CY2013Q3	us-gaap	Revenues Revenues	1076000	usd
CY2013Q4	us-gaap	Revenues Revenues	1009000	usd
CY2013	us-gaap	Revenues Revenues	3717000	usd
CY2014Q1	us-gaap	Revenues Revenues	1014000	usd
CY2014Q2	us-gaap	Revenues Revenues	865000	usd
CY2014Q3	us-gaap	Revenues Revenues	1126000	usd
CY2014Q4	us-gaap	Revenues Revenues	1735000	usd
CY2014	us-gaap	Revenues Revenues	4740000	usd
CY2015Q1	us-gaap	Revenues Revenues	2263000	usd
CY2015Q2	us-gaap	Revenues Revenues	2776000	usd
CY2015Q3	us-gaap	Revenues Revenues	3113000	usd
CY2015Q4	us-gaap	Revenues Revenues	2963000	usd
CY2015	us-gaap	Revenues Revenues	11115000	usd
CY2013Q1	us-gaap	Cost Of Revenue CostOfRevenue	16000	usd
CY2013Q2	us-gaap	Cost Of Revenue CostOfRevenue	662000	usd
CY2013Q3	us-gaap	Cost Of Revenue CostOfRevenue	765000	usd
CY2013Q4	us-gaap	Cost Of Revenue CostOfRevenue	199000	usd
CY2013	us-gaap	Cost Of Revenue CostOfRevenue	1642000	usd
CY2014Q1	us-gaap	Cost Of Revenue CostOfRevenue	166000	usd
CY2014Q2	us-gaap	Cost Of Revenue CostOfRevenue	452000	usd
CY2014Q3	us-gaap	Cost Of Revenue CostOfRevenue	422000	usd
CY2014Q4	us-gaap	Cost Of Revenue CostOfRevenue	469000	usd
CY2014	us-gaap	Cost Of Revenue CostOfRevenue	1509000	usd
CY2015Q1	us-gaap	Cost Of Revenue CostOfRevenue	338000	usd
CY2015Q2	us-gaap	Cost Of Revenue CostOfRevenue	737000	usd
CY2015Q3	us-gaap	Cost Of Revenue CostOfRevenue	909000	usd
CY2015Q4	us-gaap	Cost Of Revenue CostOfRevenue	1796000	usd
CY2015	us-gaap	Cost Of Revenue CostOfRevenue	3780000	usd
CY2013Q1	us-gaap	Gross Profit GrossProfit	532000	usd
CY2013Q2	us-gaap	Gross Profit GrossProfit	422000	usd
CY2013Q3	us-gaap	Gross Profit GrossProfit	311000	usd
CY2013Q4	us-gaap	Gross Profit GrossProfit	810000	usd
CY2013	us-gaap	Gross Profit GrossProfit	2075000	usd
CY2014Q1	us-gaap	Gross Profit GrossProfit	848000	usd
CY2014Q2	us-gaap	Gross Profit GrossProfit	413000	usd
CY2014Q3	us-gaap	Gross Profit GrossProfit	704000	usd
CY2014Q4	us-gaap	Gross Profit GrossProfit	1266000	usd
CY2014	us-gaap	Gross Profit GrossProfit	3231000	usd
CY2015Q1	us-gaap	Gross Profit GrossProfit	1925000	usd
CY2015Q2	us-gaap	Gross Profit GrossProfit	2039000	usd
CY2015Q3	us-gaap	Gross Profit GrossProfit	2204000	usd
CY2015Q4	us-gaap	Gross Profit GrossProfit	1167000	usd
CY2015	us-gaap	Gross Profit GrossProfit	7335000	usd
CY2013	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7235000	usd
CY2014	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7373000	usd
CY2015	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6279000	usd
CY2013	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2732000	usd
CY2014	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3250000	usd
CY2015	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3753000	usd
CY2013	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5079000	usd
CY2014	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6799000	usd
CY2015	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4999000	usd
CY2013	us-gaap	Operating Expenses OperatingExpenses	15046000	usd
CY2014	us-gaap	Operating Expenses OperatingExpenses	17422000	usd
CY2015	us-gaap	Operating Expenses OperatingExpenses	15031000	usd
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	-12971000	usd
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	-14191000	usd
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	-7696000	usd
CY2013	us-gaap	Interest Expense InterestExpense		usd
CY2014	us-gaap	Interest Expense InterestExpense	14000	usd
CY2015	us-gaap	Interest Expense InterestExpense	18000	usd
CY2013	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2014	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-16000	usd
CY2015	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-28000	usd
CY2013	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense		usd
CY2014	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-30000	usd
CY2015	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-46000	usd
CY2013	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-12971000	usd
CY2014	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-14221000	usd
CY2015	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-7742000	usd
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	109000	usd
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13000	usd
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	93000	usd
CY2013	us-gaap	Profit Loss ProfitLoss	-13080000	usd
CY2014	us-gaap	Profit Loss ProfitLoss	-14234000	usd
CY2015	us-gaap	Profit Loss ProfitLoss	-7835000	usd
CY2013	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2014	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2015	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-15000	usd
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	-3570000	usd
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	-3120000	usd
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	-3343000	usd
CY2013Q4	us-gaap	Net Income Loss NetIncomeLoss	-3047000	usd
CY2013	us-gaap	Net Income Loss NetIncomeLoss	-13080000	usd
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	-4008000	usd
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	-3874000	usd
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	-3245000	usd
CY2014Q4	us-gaap	Net Income Loss NetIncomeLoss	-3107000	usd
CY2014	us-gaap	Net Income Loss NetIncomeLoss	-14234000	usd
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	-2072000	usd
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	-1792000	usd
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	-1368000	usd
CY2015Q4	us-gaap	Net Income Loss NetIncomeLoss	-2588000	usd
CY2015	us-gaap	Net Income Loss NetIncomeLoss	-7820000	usd
CY2013Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.11
CY2013Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.09
CY2013Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.09
CY2013Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.08
CY2013	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.37
CY2014Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.11
CY2014Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.10
CY2014Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.08
CY2014Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.08
CY2014	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.36
CY2015Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.05
CY2015Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.04
CY2015Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.03
CY2015Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.06
CY2015	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.19
CY2013	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	35266000	shares
CY2014	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	39532000	shares
CY2015	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	41202000	shares
CY2013	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	6000	usd
CY2014	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	138000	usd
CY2015	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-103000	usd
CY2013	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-13074000	usd
CY2014	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-14096000	usd
CY2015	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-7938000	usd
CY2013	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest		usd
CY2014	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest		usd
CY2015	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	15000	usd
CY2013	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13074000	usd
CY2014	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-14096000	usd
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7953000	usd
CY2013	neond	Stock Issued During Period Value Employee Stock Option And Warrant Compensation Expense StockIssuedDuringPeriodValueEmployeeStockOptionAndWarrantCompensationExpense	2656000	usd
CY2014	neond	Stock Option And Warrant Compensation Expense To Employees Directors And Vendors StockOptionAndWarrantCompensationExpenseToEmployeesDirectorsAndVendors	1729000	usd
CY2015	neond	Stock Option And Warrant Compensation Expense To Employees Directors And Vendors StockOptionAndWarrantCompensationExpenseToEmployeesDirectorsAndVendors	1075000	usd
CY2013	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	6892000	usd
CY2014	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	9253000	usd
CY2015	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5422000	usd
CY2015Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	3200000	shares
CY2015Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	1800000	shares
CY2013	neond	Common Stock Issued Upon Exercise Of Common Stock Warrants CommonStockIssuedUponExerciseOfCommonStockWarrants	714000	usd
CY2014	neond	Common Stock Issued Upon Exercise Of Common Stock Warrants CommonStockIssuedUponExerciseOfCommonStockWarrants		usd
CY2015	neond	Common Stock Issued Upon Exercise Of Common Stock Warrants CommonStockIssuedUponExerciseOfCommonStockWarrants	1000	usd
CY2013	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1060000	usd
CY2015	neond	Non Controlling Interests Pronode Initial Investment NonControllingInterestsPronodeInitialInvestment	3000	usd
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	2656000	usd
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	1729000	usd
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	1075000	usd
CY2013	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2014	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	167000	usd
CY2015	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2013	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	144000	usd
CY2014	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	202000	usd
CY2015	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	187000	usd
CY2013	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-8000	usd
CY2014	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-16000	usd
CY2015	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-28000	usd
CY2013	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1155000	usd
CY2014	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	304000	usd
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	239000	usd
CY2013	neond	Projects In Process ProjectsInProcess	736000	usd
CY2014	neond	Projects In Process ProjectsInProcess	-530000	usd
CY2015	neond	Projects In Process ProjectsInProcess	-38000	usd
CY2013	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-95000	usd
CY2014	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	60000	usd
CY2015	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	263000	usd
CY2013	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	19000	usd
CY2014	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	363000	usd
CY2015	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	871000	usd
CY2013	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	938000	usd
CY2014	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-233000	usd
CY2015	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1925000	usd
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8801000	usd
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11824000	usd
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8063000	usd
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	155000	usd
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	115000	usd
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	198000	usd
CY2013	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
CY2014	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	7000	usd
CY2015	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-155000	usd
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-108000	usd
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-198000	usd
CY2013	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1060000	usd
CY2014	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2015	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2013	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	714000	usd
CY2014	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	36000	usd
CY2015	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2013	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6892000	usd
CY2014	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	9253000	usd
CY2015	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5422000	usd
CY2013	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders		usd
CY2014	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders		usd
CY2015	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	3000	usd
CY2013	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations		usd
CY2014	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	34000	usd
CY2015	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	57000	usd
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8666000	usd
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9255000	usd
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5368000	usd
CY2013	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	8000	usd
CY2014	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-9000	usd
CY2015	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-154000	usd
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-282000	usd
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-2686000	usd
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-3047000	usd
CY2013	us-gaap	Interest Paid InterestPaid		usd
CY2014	us-gaap	Interest Paid InterestPaid	14000	usd
CY2015	us-gaap	Interest Paid InterestPaid	18000	usd
CY2013	us-gaap	Income Taxes Paid IncomeTaxesPaid	109000	usd
CY2014	us-gaap	Income Taxes Paid IncomeTaxesPaid	5000	usd
CY2015	us-gaap	Income Taxes Paid IncomeTaxesPaid	93000	usd
CY2013	neond	Supplemental Non Cash Purchase Of Equipment With Capital Lease Obligation SupplementalNonCashPurchaseOfEquipmentWithCapitalLeaseObligation		usd
CY2014	neond	Supplemental Non Cash Purchase Of Equipment With Capital Lease Obligation SupplementalNonCashPurchaseOfEquipmentWithCapitalLeaseObligation	530000	usd
CY2015	neond	Supplemental Non Cash Purchase Of Equipment With Capital Lease Obligation SupplementalNonCashPurchaseOfEquipmentWithCapitalLeaseObligation		usd
CY2015	us-gaap	Nature Of Operations NatureOfOperations	<table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0"> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-stretch: normal;"> <td style="font: 10pt/normal 'times new roman', times, serif; width: 0.25in; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>1.</b></font></td> <td style="font: 10pt/normal 'times new roman', times, serif; text-indent: 0pt; padding-left: 0pt; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>Nature of the Business and Operations</b></font></td> </tr> </table> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 18pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b> </b></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 18pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b>Background and Organization</b></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 18pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 36pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Neonode Inc. (“we”, “us”, “our”, or the “Company”) was incorporated in the State of Delaware in 1997 as the parent of Neonode AB, a company founded in February 2004 and incorporated in Sweden. On December 29, 2008, we entered into a share exchange agreement with AB Cypressen nr 9683 (renamed Neonode Technologies AB), a Swedish engineering company, and Neonode Technologies AB became our wholly owned subsidiary. In 2013, we established additional wholly owned subsidiaries: Neonode Japan Inc. (Japan); Neno User Interface Solutions AB (Sweden); NEON Technology Inc. (U.S.); and Neonode Americas Inc. (U.S.). In 2014, we established one additional wholly owned subsidiary: Neonode Korea Ltd. (South Korea). In 2015, we established one additional wholly owned subsidiary: Neonode Taiwan Ltd. (Taiwan). In 2015 we established Pronode Technologies AB, a majority-owned subsidiary of Neonode Technologies AB.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 36pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 36pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b><i>Operations</i></b></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 36pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Neonode Inc., collectively with its subsidiaries, is referred to as “Neonode”, develops and licenses user interfaces and optical touch technology to Original Equipment Manufacturers (“OEMs”) and Original Design Manufacturers (“ODMs”) who embed the Neonode technology into devices that they produce and sell.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 36pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 36pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b><i>Reclassifications</i></b></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 36pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 36pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Interest expense for the year ended December 31, 2014 is now reported under its own caption, separate from other expense, in the accompanying consolidated statement of operations, in order to conform to the current period presentation.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 36pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 36pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b><i>Liquidity</i></b></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 36pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 36pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">We incurred net losses of approximately $7.8 million, $14.2 million and $13.1 million for the years ended December 31, 2015, 2014 and 2013, respectively and had an accumulated deficit of approximately $173.7 million as of December 31, 2015. In addition, we used cash in operating activities of approximately $8.1 million, $11.8 million and $8.8 million for the years ended December 31, 2015, 2014 and 2013, respectively.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 36pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"> </font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 36pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">In June 2014, we filed a shelf registration statement with the SEC that became effective on June 12, 2014. We may from time to time issue shares of our common stock under our shelf registration in amounts, at prices, and on terms to be announced when and if the securities are offered. The specifics of any future offerings, along with the use of proceeds of any securities offered, will be described in a prospectus supplement and any other offering materials, at the time of the offering. Our shelf registration statement will expire on June 12, 2017.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 9pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 36pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">On October 13, 2015, we issued 3,200,000 shares of our common stock from our shelf registration statement to investors in connection with an equity financing transaction. We sold the stock at $1.90 per share and raised approximately $6.1 million gross and received approximately $5.4 million in cash, net of direct offering costs including underwriting discounts and legal, audit and other regulatory costs of approximately $0.7 million.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 36pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 36pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">As of December 31, 2015, there were 1,800,000 shares remaining for issuance under our existing shelf registration statement.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 49.5pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"> </font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">We believe that, based upon our current operating plan, our existing cash and cash provided by operations will be sufficient to meet our anticipated cash needs for at least the next twelve months. We expect that our revenues from license fees and non-recurring engineering fees will enable us to reduce, or eliminate, our operating losses in 2016. We also have undertaken steps to reduce operating expenses, including (i) termination of consulting contracts associated with our research and development operations, and (ii) improving overall cost efficiency of our operations. Depending on our cash flow, we intend to continue to implement various measures to improve our financial condition, such as reducing further expenses to conserve cash and pursuing strategic transactions and relationships with third parties. While there is no assurance that the Company can meet its projected cash flows, management anticipates that it can continue operations for at least the next twelve months.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 36pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"> </font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 36pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">In the future, we may require sources of capital in addition to cash on hand to continue operations and to implement our strategy. If our operations do not become cash flow positive, we may be forced to seek credit line facilities from financial institutions, equity investments or debt arrangements. No assurances can be given that we will be successful in obtaining such additional financing on reasonable terms, or at all. If adequate funds are not available on acceptable terms, or at all, we may be unable to adequately fund our business plans and it could have a negative effect on our business, results of operations and financial condition. In addition, if funds are available, the issuance of equity securities or securities convertible into equity could dilute the value of shares of our common stock and cause the market price to fall, and the issuance of debt securities could impose restrictive covenants that could impair our ability to engage in certain business transactions.</font></p>
CY2015	us-gaap	Use Of Estimates UseOfEstimates	<p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 18pt;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;"><b><i>Estimates</i></b></font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 18pt;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;"> </font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 36pt;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">The preparation of financial statements in conformity with U.S. GAAP requires making estimates and assumptions that affect, at the date of the financial statements, the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenue and expenses. Actual results could differ from these estimates. Significant estimates include, but are not limited to, collectability of accounts receivable, the achievement of substantive milestones and vendor-specific objective evidence (“VSOE”) of fair value for purposes of revenue recognition (or deferral of revenue), recoverability of capitalized project costs and long-lived assets, the valuation allowance related to our deferred tax assets, and the fair value of options and warrants issued for stock-based compensation.</font></p>
CY2015	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 18pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b><i>Concentration of Credit and Business Risks</i></b></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 36pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 36pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Our customers are located in U.S., Europe and Asia.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 36pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"> </font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">As of December 31, 2015, three customers represented approximately 78% of our consolidated accounts receivable.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">As of December 31, 2014, three customers represented approximately 87% of our consolidated accounts receivable.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 36pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;"> </font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 36pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Our net revenues for the year ended December 31, 2015 were earned from thirty-five customers. Customers who accounted for 10% or more of our net revenues during the year ended December 31, 2015 are as follows.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 36pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </font></p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-stretch: normal;"> <td style="font: 10pt/normal 'times new roman', times, serif; width: 48px; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </font></td> <td style="font: 10pt/normal 'times new roman', times, serif; width: 24px; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">●</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Hewlett-Packard Company – 25%</font></td> </tr> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-stretch: normal;"> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </font></td> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">●</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Autoliv – 21%</font></td> </tr> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-stretch: normal;"> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </font></td> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">●</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Amazon – 14%</font></td> </tr> </table> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 36pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 36pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Our net revenues for the year ended December 31, 2014 were earned from thirty-two customers. Customers who accounted for 10% or more of our net revenues during the year ended December 31, 2014 are as follows.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 36pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </font></p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-stretch: normal;"> <td style="font: 10pt/normal 'times new roman', times, serif; width: 48px; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </font></td> <td style="font: 10pt/normal 'times new roman', times, serif; width: 24px; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">●</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Hewlett-Packard Company – 24%</font></td> </tr> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-stretch: normal;"> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </font></td> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">●</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">KOBO Inc. – 10%</font></td> </tr> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-stretch: normal;"> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </font></td> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">●</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Leap Frog Enterprises Inc. – 11%</font></td> </tr> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-stretch: normal;"> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </font></td> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">●</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Sony Corporation – 10%</font></td> </tr> </table> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 36pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 36pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Our revenues for the year ended December 31, 2013 were earned from twenty-nine customers. Customers who accounted for 10% or more of our net revenues during the year ended December 31, 2013 are as follows.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 36pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </font></p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-stretch: normal;"> <td style="font: 10pt/normal 'times new roman', times, serif; width: 48px; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </font></td> <td style="font: 10pt/normal 'times new roman', times, serif; width: 24px; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">●</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">KOBO Inc. – 28%</font></td> </tr> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-stretch: normal;"> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </font></td> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">●</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Netronix Inc. – 18%</font></td> </tr> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-stretch: normal;"> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </font></td> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">●</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Leap Frog Enterprises Inc. – 12%</font></td> </tr> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-stretch: normal;"> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </font></td> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">●</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Sony Corporation – 11%</font></td> </tr> </table> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 36pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 36pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company conducts business in the U.S., Europe and Asia. At December 31, 2015, the Company maintained approximately $2,533,000, ($909,000) and $209,000 of its net assets (liabilities) in the U.S., Europe and Asia, respectively. At December 31, 2014, the Company maintained approximately $3,713,000, ($461,000) and $18,000 of its net assets (liabilities) in the U.S., Europe and Asia, respectively.</p>
CY2015	us-gaap	Revenue Recognition Deferred Revenue RevenueRecognitionDeferredRevenue	<p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 18pt;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;"><b><i>Deferred Revenues</i></b></font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;"> </font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 36pt;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">We defer license fees until we have met all accounting requirements for revenue recognition as per unit royalty products are distributed and royalty reports are received. Engineering development fee revenues are deferred until such time as the engineering work has been completed and accepted by our customers. As of December 31, 2015 and 2014, we have $1.1 million and $3.0 million, respectively, of deferred license fee revenue related to prepayments for future license fees from two and four customers, respectively and a total of $0.4 million and $0.4 million, respectively, of deferred engineering development fees from one and five customers, respectively.</font></p>
CY2015Q4	us-gaap	Share Price SharePrice	1.90
CY2015Q4	neond	Stock Issued During Period Values Issued For Cash StockIssuedDuringPeriodValuesIssuedForCash	6100000	usd
CY2015Q4	us-gaap	Cash Cash	5400000	usd
CY2015Q4	neond	Direct Offering Cost DirectOfferingCost	700000	usd
CY2015Q4	us-gaap	Minority Interest Ownership Percentage By Parent MinorityInterestOwnershipPercentageByParent	0.51	pure
CY2015Q4	us-gaap	Minority Interest Ownership Percentage By Noncontrolling Owners MinorityInterestOwnershipPercentageByNoncontrollingOwners	0.49	pure
CY2015Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	100000	sek
CY2015Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2015Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	3000000	twd
CY2015Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	50000000	krw
CY2015Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	10000000	jpy
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	167000	usd
CY2015Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	167000	usd
CY2014	us-gaap	Environmental Costs Recognized Capitalized In Period EnvironmentalCostsRecognizedCapitalizedInPeriod	200000	usd
CY2015	us-gaap	Environmental Costs Recognized Capitalized In Period EnvironmentalCostsRecognizedCapitalizedInPeriod	158000	usd
CY2013	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	-155000	usd
CY2014	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	-37000	usd
CY2015	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	62000	usd
CY2013	us-gaap	Cost Of Goods Sold CostOfGoodsSold		usd
CY2014	us-gaap	Cost Of Goods Sold CostOfGoodsSold		usd
CY2015	us-gaap	Cost Of Goods Sold CostOfGoodsSold	165000	usd
CY2013	us-gaap	Advertising Expense AdvertisingExpense	141000	usd
CY2014	us-gaap	Advertising Expense AdvertisingExpense	172000	usd
CY2015	us-gaap	Advertising Expense AdvertisingExpense	328000	usd
CY2015	us-gaap	Minority Interest Description MinorityInterestDescription	Noncontrolling interests' partners have less than 50% share of voting rights at any one of the subsidiary level companies.
CY2013	neond	Number Of Customers NumberOfCustomers	32	customers
CY2014	neond	Number Of Customers NumberOfCustomers	29	customers
CY2015	neond	Number Of Customers NumberOfCustomers	35	customers
CY2014Q4	us-gaap	Prepaid Insurance PrepaidInsurance	122000	usd
CY2015Q4	us-gaap	Prepaid Insurance PrepaidInsurance	119000	usd
CY2014Q4	us-gaap	Prepaid Rent PrepaidRent	39000	usd
CY2015Q4	us-gaap	Prepaid Rent PrepaidRent	52000	usd
CY2014Q4	us-gaap	Prepaid Taxes PrepaidTaxes	137000	usd
CY2015Q4	us-gaap	Prepaid Taxes PrepaidTaxes	337000	usd
CY2014Q4	us-gaap	Other Assets Current OtherAssetsCurrent	215000	usd
CY2015Q4	us-gaap	Other Assets Current OtherAssetsCurrent	239000	usd
CY2014Q4	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	458000	usd
CY2015Q4	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	428000	usd
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	350000	usd
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	471000	usd
CY2014Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	686000	usd
CY2015Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	932000	usd
CY2014Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	249000	usd
CY2015Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	382000	usd
CY2013Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	7700000	usd
CY2013Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	166000	usd
CY2013Q2	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	40000	usd
CY2013Q3	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	800000	usd
CY2014	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	700000	usd
CY2014Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	3.14
CY2015Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	1.24
CY2014	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	10000000	usd
CY2013Q3	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	1168939	shares
CY2014	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	2500000	shares
CY2014Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	4.00
CY2013Q3	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	6900000	usd
CY2014	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	9300000	usd
CY2014	neond	Placement Agent Fee PlacementAgentFee	600000	usd
CY2014	neond	Purchase Of Common Stock By Warrant Issued PurchaseOfCommonStockByWarrantIssued	2500000	shares
CY2014Q2	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	5000000	shares
CY2013Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.00
CY2014Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	5.09
CY2014	neond	Warrants Issued To Placement Agent WarrantsIssuedToPlacementAgent	75000	shares
CY2013Q2	neond	Stock Purchase Warrant StockPurchaseWarrant	40000	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1709400	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y3M18D
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y6M
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y11M19D
CY2013	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2656000	usd
CY2014	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1729000	usd
CY2015	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1075000	usd
CY2015Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	520000	usd
CY2015Q4	neond	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Warrants Outstanding And Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsWarrantsOutstandingAndExercisableNumber	464073	shares
CY2014	neond	Stock Based Compensation Options Granted To Purchase Of Common Stock To Employee StockBasedCompensationOptionsGrantedToPurchaseOfCommonStockToEmployee	10000	shares
CY2015	neond	Stock Based Compensation Options Granted To Purchase Of Common Stock To Employee StockBasedCompensationOptionsGrantedToPurchaseOfCommonStockToEmployee	90000	shares
CY2013	neond	Stock Based Compensation Options Granted To Purchase Of Common Stock To Board Members StockBasedCompensationOptionsGrantedToPurchaseOfCommonStockToBoardMembers	145000	shares
CY2014	neond	Stock Based Compensation Options Granted To Purchase Of Common Stock To Board Members StockBasedCompensationOptionsGrantedToPurchaseOfCommonStockToBoardMembers	395200	shares
CY2015	neond	Stock Based Compensation Options Granted To Purchase Of Common Stock To Board Members StockBasedCompensationOptionsGrantedToPurchaseOfCommonStockToBoardMembers	515000	shares
CY2013	neond	Stock Based Compensation Options Granted To Purchase Of Common Stock To Employee Fair Value StockBasedCompensationOptionsGrantedToPurchaseOfCommonStockToEmployeeFairValue	748000	usd
CY2014	neond	Stock Based Compensation Options Granted To Purchase Of Common Stock To Employee Fair Value StockBasedCompensationOptionsGrantedToPurchaseOfCommonStockToEmployeeFairValue	1300000	usd
CY2015	neond	Stock Based Compensation Options Granted To Purchase Of Common Stock To Employee Fair Value StockBasedCompensationOptionsGrantedToPurchaseOfCommonStockToEmployeeFairValue	800000	usd
CY2013	neond	Stock Options Vesting Period Description StockOptionsVestingPeriodDescription	The options have a 7-year life and 1/3 of the options are vested on the one year anniversary date of grant with the remaining to vest monthly over the next 24-months.
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	741000	usd
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	646000	usd
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two And Three Years OperatingLeasesFutureMinimumPaymentsDueInTwoAndThreeYears	93000	usd
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	1480000	usd
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Due In Rolling Year Two CapitalLeasesFutureMinimumPaymentsDueInRollingYearTwo	72000	usd
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Due In Rolling Year Three CapitalLeasesFutureMinimumPaymentsDueInRollingYearThree	72000	usd
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Due In Rolling Year Four CapitalLeasesFutureMinimumPaymentsDueInRollingYearFour	72000	usd
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Due In Rolling Year Five CapitalLeasesFutureMinimumPaymentsDueInRollingYearFive	72000	usd
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Due In Rolling After Year Five CapitalLeasesFutureMinimumPaymentsDueInRollingAfterYearFive	94000	usd
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	382000	usd
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	42000	usd
CY2015Q4	us-gaap	Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments	340000	usd
CY2015Q4	us-gaap	Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation	95000	usd
CY2015Q4	us-gaap	Capital Leases Balance Sheet Assets By Major Class Net CapitalLeasesBalanceSheetAssetsByMajorClassNet	332000	usd
CY2010Q1	neond	Nonrecurring Development Cost NonrecurringDevelopmentCost	500000	usd
CY2012Q4	neond	Nonrecurring Development Cost NonrecurringDevelopmentCost	500000	usd
CY2010Q1	neond	Description Of Development Cost Contributed DescriptionOfDevelopmentCostContributed	Under the terms of the NN1001 Agreement, we will reimburse TI an NRE fee of $0.08 per unit for each of the first one million units sold and $0.05 for the next eight million units sold.
CY2012Q4	neond	Description Of Development Cost Contributed DescriptionOfDevelopmentCostContributed	Under the terms of the NN1002 Agreement we will reimburse TI an NRE fee of $0.25 per unit for each of the first two million units sold.
CY2010Q1	neond	Nonrecurring Development Cost One NonrecurringDevelopmentCostOne	0.08
CY2010Q1	neond	Nonrecurring Development Cost Two NonrecurringDevelopmentCostTwo	0.05
CY2012Q4	neond	Non Recurring Development Cost Three NonRecurringDevelopmentCostThree	0.25
CY2014	neond	Nonrecurring Expense Related To Agreement NonrecurringExpenseRelatedToAgreement	93000	usd
CY2015	neond	Nonrecurring Expense Related To Agreement NonrecurringExpenseRelatedToAgreement	20000	usd
CY2015	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	160000	usd
CY2014Q2	neond	Capital Lease Term Of Contract CapitalLeaseTermOfContract	P6Y
CY2014Q2	us-gaap	Description Of Lessee Leasing Arrangements Capital Leases DescriptionOfLesseeLeasingArrangementsCapitalLeases	Under the terms of the lease agreement we are obligated to purchase the equipment at the end of the original 6 year lease term for 10% of the original purchase price of the equipment.
CY2014Q2	us-gaap	Capital Leases Income Statement Amortization Expense CapitalLeasesIncomeStatementAmortizationExpense	16000	usd
CY2014Q2	us-gaap	Capital Leases Of Lessee Contingent Rentals Basis Spread On Variable Rate CapitalLeasesOfLesseeContingentRentalsBasisSpreadOnVariableRate	0.04	pure
CY2015Q4	us-gaap	Area Of Real Estate Property AreaOfRealEstateProperty	6508	sqft
CY2014	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2015-07-31
CY2015	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2018-07-31
CY2013	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	556000	usd
CY2014	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	633000	usd
CY2015	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	641000	usd
CY2013	neond	Revenue Percentage Net RevenuePercentageNet	1.00	pure
CY2014	neond	Revenue Percentage Net RevenuePercentageNet	1.00	pure
CY2015	neond	Revenue Percentage Net RevenuePercentageNet	1.00	pure
CY2015	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-12877000	usd
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-13993000	usd
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-7783000	usd
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-94000	usd
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-228000	usd
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	41000	usd
CY2013	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2014	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2015	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2013	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2000	usd
CY2014	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	3000	usd
CY2015	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2000	usd
CY2013	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	107000	usd
CY2014	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	10000	usd
CY2015	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	91000	usd
CY2013	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-3794000	usd
CY2014	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-4213000	usd
CY2015	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-2466000	usd
CY2013	neond	Change In Deferred Tax Assets Valuation Allowance Federal ChangeInDeferredTaxAssetsValuationAllowanceFederal	-3794000	usd
CY2014	neond	Change In Deferred Tax Assets Valuation Allowance Federal ChangeInDeferredTaxAssetsValuationAllowanceFederal	-4213000	usd
CY2015	neond	Change In Deferred Tax Assets Valuation Allowance Federal ChangeInDeferredTaxAssetsValuationAllowanceFederal	-2466000	usd
CY2013	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	129000	usd
CY2013	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	111000	usd
CY2014	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	64000	usd
CY2015	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	6000	usd
CY2013	neond	Change In Deferred Tax Assets Valuation Allowance Foreign ChangeInDeferredTaxAssetsValuationAllowanceForeign	111000	usd
CY2014	neond	Change In Deferred Tax Assets Valuation Allowance Foreign ChangeInDeferredTaxAssetsValuationAllowanceForeign	64000	usd
CY2015	neond	Change In Deferred Tax Assets Valuation Allowance Foreign ChangeInDeferredTaxAssetsValuationAllowanceForeign	6000	usd
CY2013	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	109000	usd
CY2014	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	13000	usd
CY2015	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	93000	usd
CY2013	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34	pure
CY2014	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-460000	usd
CY2015	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-252000	usd
CY2013	neond	Change In Deferred Tax Assets Valuation Allowance State And Local ChangeInDeferredTaxAssetsValuationAllowanceStateAndLocal	129000	usd
CY2014	neond	Change In Deferred Tax Assets Valuation Allowance State And Local ChangeInDeferredTaxAssetsValuationAllowanceStateAndLocal	-460000	usd
CY2015	neond	Change In Deferred Tax Assets Valuation Allowance State And Local ChangeInDeferredTaxAssetsValuationAllowanceStateAndLocal	-252000	usd
CY2014	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34	pure
CY2015	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34	pure
CY2013	neond	Effective Income Tax Rate Reconciliation Foreign Losses At Different Rates EffectiveIncomeTaxRateReconciliationForeignLossesAtDifferentRates		pure
CY2014	neond	Effective Income Tax Rate Reconciliation Foreign Losses At Different Rates EffectiveIncomeTaxRateReconciliationForeignLossesAtDifferentRates	-0.01	pure
CY2015	neond	Effective Income Tax Rate Reconciliation Foreign Losses At Different Rates EffectiveIncomeTaxRateReconciliationForeignLossesAtDifferentRates		pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.03	pure
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.02	pure
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.01	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.01	pure
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.01	pure
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.01	pure
CY2013	neond	Effective Income Tax Rate Reconciliation Before Valuation Allowance EffectiveIncomeTaxRateReconciliationBeforeValuationAllowance	0.30	pure
CY2014	neond	Effective Income Tax Rate Reconciliation Before Valuation Allowance EffectiveIncomeTaxRateReconciliationBeforeValuationAllowance	0.30	pure
CY2015	neond	Effective Income Tax Rate Reconciliation Before Valuation Allowance EffectiveIncomeTaxRateReconciliationBeforeValuationAllowance	0.32	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.31	pure
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.31	pure
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.33	pure
CY2013	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.01	pure
CY2014	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.01	pure
CY2015	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.01	pure
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	1053000	usd
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	1109000	usd
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1210000	usd
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1352000	usd
CY2014Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	14681000	usd
CY2015Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	17190000	usd
CY2014Q4	neond	Deferred Tax Assets Basis Difference In Fixed Assets DeferredTaxAssetsBasisDifferenceInFixedAssets	-2000	usd
CY2015Q4	neond	Deferred Tax Assets Basis Difference In Fixed Assets DeferredTaxAssetsBasisDifferenceInFixedAssets	-7000	usd
CY2014Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	16946000	usd
CY2015Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	19658000	usd
CY2014Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	16946000	usd
CY2015Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	19658000	usd
CY2014Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2015Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2013	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
CY2014	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
CY2015	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
CY2014Q4	neond	Accrued Interest And Penalties Related To Uncertain Tax AccruedInterestAndPenaltiesRelatedToUncertainTax	0	usd
CY2015Q4	neond	Accrued Interest And Penalties Related To Uncertain Tax AccruedInterestAndPenaltiesRelatedToUncertainTax	0	usd
CY2015Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	80000	usd
CY2015	neond	Description Of Income Tax Withholding DescriptionOfIncomeTaxWithholding	Payments related to the license agreement with Sony Corporation are net of 10% income tax withholding as required by the Japanese government under the Sweden and Japan international tax treaty.
CY2013	neond	Amount Withheld To Offset Future Tax Liability AmountWithheldToOffsetFutureTaxLiability	42000	usd
CY2014	neond	Amount Withheld To Offset Future Tax Liability AmountWithheldToOffsetFutureTaxLiability	0	usd
CY2015	neond	Amount Withheld To Offset Future Tax Liability AmountWithheldToOffsetFutureTaxLiability	0	usd
CY2015	neond	Open Tax Years OpenTaxYears	1999 through 2014
CY2013	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35266	shares
CY2014	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39532	shares
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41202	shares

Files In Submission

Name	View Source	Status
0001213900-16-011504-index-headers.html	Edgar Link	pending
0001213900-16-011504-index.html	Edgar Link	pending
0001213900-16-011504.txt	Edgar Link	pending
0001213900-16-011504-xbrl.zip	Edgar Link	pending
f10k2015ex10iv_neonode.htm	Edgar Link	pending
f10k2015ex10viii_neonode.htm	Edgar Link	pending
f10k2015ex10vii_neonode.htm	Edgar Link	pending
f10k2015ex10vi_neonode.htm	Edgar Link	pending
f10k2015ex10v_neonode.htm	Edgar Link	pending
f10k2015ex21_neonodeinc.htm	Edgar Link	pending
f10k2015ex23i_neonodeinc.htm	Edgar Link	pending
f10k2015ex31ii_neonodeinc.htm	Edgar Link	pending
f10k2015ex31i_neonodeinc.htm	Edgar Link	pending
f10k2015ex32_neonodeinc.htm	Edgar Link	pending
f10k2015_neonodeinc.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
neond-20151231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
neond-20151231_cal.xml	Edgar Link	unprocessable
neond-20151231_def.xml	Edgar Link	unprocessable
neond-20151231_lab.xml	Edgar Link	unprocessable
neond-20151231_pre.xml	Edgar Link	unprocessable
neond-20151231.xml	Edgar Link	completed
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NEON
Neonode Inc Stock $neon

2014 Q4 Form 10-K Financial Statement

#000121390016011504 Filed on March 11, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NEON Neonode Inc Stock $neon

2014 Q4 Form 10-K Financial Statement

#000121390016011504 Filed on March 11, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NEON
Neonode Inc Stock $neon